Navigation Links
Ekahau Announces Compatibility With 802.11n
Date:5/29/2008

RTLS and Site Survey Products to Support New Wi-Fi Standard

SARATOGA, California, May 29 /PRNewswire/ -- Ekahau Inc., a leading provider of Wi-Fi-based Real Time Location Systems (RTLS), today announced that its Ekahau RTLS location tracking solution and Ekahau Site Survey (ESS) Wi-Fi network planning and optimization tools will work seamlessly with the upcoming 802.11n standard.

Enterprises are already embracing 802.11n because it offers a number of performance gains, including radio coverage and speed. ABI Research forecasts that 47 percent of all 2008 Wi-Fi chipset shipments will be 802.11n draft 2.0. Ekahau's announcement strengthens the company's leadership position in the Wi-Fi RTLS and site survey markets, and confirms that its technology continues to support the evolution of Wi-Fi and the standards themselves.

"802.11n is the next big wave in the enterprise networking market, so it is very important that our solutions will continue working over this new standard," said Pauli Misikangas, Ekahau's CTO. "With 802.11n, the quality of signal measurements actually increases, which positively impacts accuracy of the Ekahau RTLS solution. Unlike some other less sophisticated systems, our patented probabilistic algorithms can take the full advantage of the 802.11n's MIMO technology with multiple antennas."

While providing a performance boost over the legacy systems, 802.11n is far from being a plug-and-play technology. It requires careful consideration in planning and deployment, in order to achieve the full benefits for data, voice or location use.

ESS software will help organizations with new 802.11n installations both in off-site planning and post-deployment verification and troubleshooting. ESS's graphical visualization of the network's coverage enables enterprises to "see the network" and maximize its performance. The upcoming new features ESS will provide to 802.11n users include:

- Signal prediction f
'/>"/>

SOURCE Ekahau Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. GGZ-NML Hospital Deploys Ekahau RTLS for Staff Safety in Psychiatric Care Unit
2. Ekahau Offers Clear Visibility Into Real-Time Location Tracking With Ekahau Vision
3. AT4 wireless and Ekahau Partner to Deploy Combined Asset and Staff Tracking Solution for Hospitals
4. Carolinas HealthCare Selects Ekahau for One of Nations Largest Healthcare System RTLS Deployments
5. Orphan Therapeutics Announces Initiation of Rolling NDA Submission for LUCASSIN(R) (terlipressin) for the Treatment of Hepatorenal Syndrome Type 1
6. DRAXIS Announces Completion of Sale to Jubilant
7. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
8. Hill-Rom Announces Third Quarter 2008 Dividend
9. VirtualHealth Technologies, Inc. Announces Management Appointment
10. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
11. Innolife Pharma Inc. Announces The Launching Of A New And Improved Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...OWN, W.Va., Nov. 21 New...ng whether a smokeless, spitless tobacco product a...rchers have found that RJ Reynolds, Camel Snus - t...ction - contains surprisingly high levels of nicot... than most other snuff products," said Bruce Adkin...
(Date:11/21/2008)...A, S.C., Nov. 21 U.S. N...for Quality Assurance (NCQA) ranked BlueChoice(R) ...merica,s Best Health Plans(TM), published in U.S. ..., The respected annual ranking ranks the nation,...ber satisfaction and NCQA accreditation scores. NC...
(Date:11/21/2008)...E, N.J., Nov. 21 Barr Ph... that its shareholders overwhelmingly approved the...sition of Barr by Teva Pharmaceuticals Industries ...demonstrated the overwhelming support of the trans...wney, Barr,s Chairman and CEO. "We are pleased wit...
(Date:11/21/2008)...0 B.C., a new and deadly diseaseits cause remains ...state was teeming with citizens, soldiers and refu...rta. As streets filled with corpses, social order ... returned twice and Athens lost a third of its pop... marked the beginning of the end of the Golden Age...
Breaking Medicine News(10 mins):Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3Health News:BlueChoice HealthPlan Ranks in Top Third of America's Best Health Plans 2Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Study of ancient and modern plagues finds common features 2Health News:Study of ancient and modern plagues finds common features 3Health News:Study of ancient and modern plagues finds common features 4
...therapeutic regimens are effective in suppressing ...nged treatment may be complicated by development o...spite // continued concerns over the safety of int... in clinical practice interrupt therapy for reason...
...te in vitro fertilization (IVF) baby of a single p...tions about the newborn's legal status and the sin... whose childless marriage had ended in divorce yea...ountry's first single father whose son was born th...
...obe University of Australia have found a new combi...he parasite responsible for causing malaria. They ...or treatment // helps in killing P. falciparum whi...hloroquine is a largely used drug in the treatment...
...most common breathing problems encountered by many...s been a considerable increase in the incidence of...as been estimated that nearly 196,000 children are...ry year with asthma attacks. A considerable amount...
Other Medicine News:Health News:A first for India - IVF baby born of surrogacy 2Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2
(Date:11/20/2008)..., Switzerland, November 20 /PRNewswire-FirstCall/ ...ti-infective Drugs Advisory Committee of the,U.S....o 2 against the,approval of intravenous iclaprim,...reatment of patients with complicated skin and ski...caused by methicillin-resistant Staphylococcus,au...
(Date:11/20/2008)... Calif., Nov. 20 Bionovo...ll present results from the Phase 1B,clinical tri...tatic breast,cancer, BZL101, at the Society for I...nce in Atlanta, Georgia. The Company,s oral prese...d will be presented as a part of the Best of the,...
(Date:11/20/2008)...Mass., Nov. 20 Radius Health ("Rad...onal $15 million to its second institutional finan...o $82.5 million and the total amount raised since ...sting institutional investors participated in the ...d including MPM Capital, The Wellcome Trust, Healt...
(Date:11/20/2008).... 20 PAREXEL Internation... biopharmaceutical services provider, today announ...provide regulatory consulting and clinical researc...ce, PAREXEL now has locations throughout five impo...which also include Argentina, Brazil, Chile, and M...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 2Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 3Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 4Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology 5Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 2PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 3PAREXEL Strengthens Leading Presence in Latin America With a New Location in Peru 4Mediterranean Diet May Ward Off Type 2 Diabetes 20660 1Mediterranean Diet May Ward Off Type 2 Diabetes 20660 2Mediterranean Diet May Ward Off Type 2 Diabetes 20660 3Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO 20657 1Medarex Hosts June 2nd Webcast of Ipilimumab Data Presented at ASCO 20657 2Technological Interventions Merge Into Health and Fitness 20654 1Technological Interventions Merge Into Health and Fitness 20654 2Technological Interventions Merge Into Health and Fitness 20654 3Brisk Walking Lowers Blood Pressure Increases Fitness in Obese 20651 1Brisk Walking Lowers Blood Pressure Increases Fitness in Obese 20651 2
...S WIRE)--Apr 26, 2007 - Northfield,Laboratories In...t,research organization has informed the Company t...l Phase III trauma trial with,PolyHeme(R), the Com...cell substitute, will not be complete until May., ...ories Inc. is a leader in developing an,oxygen-car...
... 0in 0pt; TEXT-ALIGN: left; tab-stops: 0in",align=...ops: list .5in; mso-list: l1 level1 lfo2">, <span ... MT,; mso-bidi-font-weight: bold">,Independent Jap...ng,Diovan to conventional therapy , , , ,<li st...so-list: l1 level1 lfo2">, <span style=,"FONT-SIZE...
Other Medicine Technology:Northfield Laboratories Investor Update 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 2Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 3Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 4Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 5Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 6Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 7Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 8Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 9Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 10Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 11Diovan Achieved 40% Reduction in Stroke and Cardiovascular Events,in Landmark Jikei Heart Study 12
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
... is a national reference laboratory and a worldwid...elopment. ARUP offers an extensive test menu of hi...and anatomic pathology. Owned by the University of...n half of the nation's university teaching hospita...
Medicine Products: